Search

everythinglearnresearchcommunity

for

Search:↓

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Oral Apremilast effectively treats alopecia areata in most patients.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Trichoscopy helps diagnose and track alopecia areata by examining specific hair and scalp markers.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

People with alopecia who are more resilient tend to feel less stressed.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

PRP treatment may help with alopecia areata, especially in newer cases.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.